Yahoo
NasdaqGS - Delayed Quote USD

Capricor Therapeutics, Inc. (CAPR)

9.40 +0.12 (+1.29%)
At close: September 4 at 4:00:01 PM EDT
9.37 -0.03 (-0.32%)
After hours: September 4 at 7:51:40 PM EDT
Trade CAPR on Coinbase

Financials

Updated 12h ago
Powered by Yahoo Scout

Capricor Therapeutics Inc's financial performance shows significant challenges, with declining growth metrics across the board, including revenue growthof 0.00%in Q2 2026, and EPS growthdown by 54.09%. Profitability metrics are concerning, with gross marginand operating marginboth at 0.00%in Q2 2026, indicating a lack of operational efficiency. Overall, Capricor's financial health is under pressure, reflecting ongoing struggles in the healthcare sector.

Valuation Measures

Currency in USD Download
Current 3/31/2026 12/31/2025 9/30/2025 6/30/2025 3/31/2025
Market Cap
582.26M 1.75B 1.66B 329.62M 453.92M 433.47M
Enterprise Value
435.37M 1.45B 1.57B 207.86M 310.39M 283.41M
Trailing P/E
-- -- -- -- -- --
Forward P/E
-- -- -- -- -- --
PEG Ratio (5yr expected)
-- -- -- -- -- --
Price/Sales
124.43 124.43 117.74 22.75 22.18 15.01
Price/Book
2.36 5.73 19.74 3.14 3.56 2.98
Enterprise Value/Revenue
141.52 141.52 141.21 15.52 17.87 12.73
Enterprise Value/EBITDA
-2.73 -- -- -- -- --
3/31/2025 - 2/13/2007

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends --
Most Recent Quarter (mrq) --

Profitability

Profit Margin --
Operating Margin (ttm) --

Management Effectiveness

Return on Assets (ttm) --
Return on Equity (ttm) --

Income Statement

Revenue (ttm) --
Revenue Per Share (ttm) --
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) --
EBITDA --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) --
Total Cash Per Share (mrq) --
Total Debt (mrq) --
Total Debt/Equity (mrq) --
Current Ratio (mrq) --
Book Value Per Share (mrq) --

Cash Flow Statement

Operating Cash Flow (ttm) --
Levered Free Cash Flow (ttm) --

Trading Information

Stock Price History

Beta (5Y Monthly) --
52 Week Change 3 --
S&P 500 52-Week Change 3 --
52 Week High 3 --
52 Week Low 3 --
50-Day Moving Average 3 --
200-Day Moving Average 3 --

Share Statistics

Avg Vol (3 month) 3 --
Avg Vol (10 day) 3 --
Shares Outstanding 5 --
Implied Shares Outstanding 6 --
Float 8 --
% Held by Insiders 1 --
% Held by Institutions 1 --
Shares Short 4 --
Short Ratio 4 --
Short % of Float 4 --
Short % of Shares Outstanding 4 --
Shares Short (prior month ) 4 --

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 --
Trailing Annual Dividend Yield 3 --
5 Year Average Dividend Yield 4 --
Payout Ratio 4 --
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq  =  Most Recent Quarter
  • ttm  =  Trailing Twelve Months
  • yoy  =  Year Over Year
  • lfy  =  Last Fiscal Year
  • fye  =  Fiscal Year Ending

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: